AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
IRME vs ENDV Fundamental Comparison
| Metric | IRME | ENDV |
|---|---|---|
| Revenue | $-3,000.0 | $134,260.0 |
| Net Income | $-1.5M | $8.5M |
| Net Margin | 49,133.3% | 6,351.8% |
| ROE | N/A | N/A |
| ROA | -842.3% | 1,045.4% |
| Current Ratio | 0.12x | 0.00x |
| Debt/Equity | N/A | N/A |
| EPS | $-0.02 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IRME vs ENDV: Frequently Asked Questions
Is IRME or ENDV a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. IRME is rated STRONG SELL (96% confidence) while ENDV is rated STRONG SELL (96% confidence). This is not investment advice.
How does IRME compare to ENDV fundamentally?
IR-Med, Inc. has ROE of N/A vs ENDONOVO THERAPEUTICS, INC.'s N/A. Net margins are 49,133.3% vs 6,351.8% respectively.
Which stock pays higher dividends, IRME or ENDV?
IRME has a dividend yield of N/A or no dividend while ENDV has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IRME or ENDV for long term?
For long-term investing, consider that IRME has STRONG SELL rating with 96% confidence, while ENDV has STRONG SELL rating with 96% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IRME vs ENDV?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IRME vs ENDV, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.